Brevan Howard Capital Management LP Buys 14,287 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Brevan Howard Capital Management LP boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 182.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 22,109 shares of the healthcare conglomerate's stock after purchasing an additional 14,287 shares during the quarter. Brevan Howard Capital Management LP's holdings in UnitedHealth Group were worth $11,184,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Sugarloaf Wealth Management LLC boosted its stake in UnitedHealth Group by 17.6% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock valued at $4,025,000 after purchasing an additional 1,193 shares during the last quarter. Signal Advisors Wealth LLC boosted its position in shares of UnitedHealth Group by 13.0% during the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock valued at $4,611,000 after buying an additional 1,051 shares during the last quarter. Waycross Partners LLC raised its position in UnitedHealth Group by 2.4% in the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock worth $14,060,000 after buying an additional 658 shares during the last quarter. Czech National Bank grew its stake in shares of UnitedHealth Group by 6.1% in the fourth quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate's stock worth $100,937,000 after acquiring an additional 11,426 shares during the period. Finally, Lmcg Investments LLC lifted its position in UnitedHealth Group by 11.8% during the fourth quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate's stock valued at $19,210,000 after purchasing an additional 4,022 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. JPMorgan Chase & Co. decreased their target price on shares of UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Wells Fargo & Company cut their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Hsbc Global Res cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 22nd. Truist Financial reduced their price objective on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a research note on Monday, April 21st. Finally, Raymond James restated a "strong-buy" rating and issued a $540.00 price target (down previously from $635.00) on shares of UnitedHealth Group in a research report on Monday, April 21st. Four analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $596.86.

UnitedHealth Group Trading Down 2.4 %

UNH stock traded down $9.60 during mid-day trading on Tuesday, reaching $395.21. 7,831,081 shares of the stock traded hands, compared to its average volume of 4,648,576. UnitedHealth Group Incorporated has a one year low of $393.11 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The business has a 50-day moving average price of $493.20 and a two-hundred day moving average price of $526.12. The stock has a market capitalization of $359.73 billion, a PE ratio of 25.50, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter last year, the firm earned $6.91 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.13%. UnitedHealth Group's dividend payout ratio is currently 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.